The Association Between Contralateral Prophylactic Mastectomy and Breast Cancer Outcomes by Hormone Receptor Status

por Brewster, A.M., Bedrosian, I., Parker, P.A., Dong, W., Peterson, S.K., Cantor, S.B., Crosby, M., Shen, Y.
Publicado em 2012

Copy Number Imbalances Between Screen and Symptom-Detected Breast Cancers and Impact on Disease-free Survival

por Brewster, A. M., Thompson, P., Sahin, A. A., Do, K., Edgerton, M., Murray, J.L., Tsavachidis, S., Zhou, R., Liu, Y, Zhang, L., Mills, G., Bondy, M.
Publicado em 2011

The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers

por Brewster, A.M., Etzel, C., Zhou, R., Wong, Y., Edge, S., Blayney, D.W, Wilson, J., Hudis, C., Ottesen, R., Hughes, M.E., Weeks, J.C., Theriault, R.L.
Publicado em 2011

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in wom...

por Gonzalez-Angulo, A. M., Akcakanat, A., Liu, S., Green, M. C., Murray, J. L., Chen, H., Palla, S. L., Koenig, K. B., Brewster, A. M., Valero, V., Ibrahim, N. K., Moulder-Thompson, S., Litton, J. K., Tarco, E., Moore, J., Flores, P., Crawford, D., Dryden, M. J., Symmans, W. F., Sahin, A., Giordano, S. H., Pusztai, L., Do, K-A., Mills, G. B., Hortobagyi, G. N., Meric-Bernstam, F.
Publicado em 2014